Jesse J.  Geiger net worth and biography

Jesse Geiger Biography and Net Worth

CFO of Medpace
Jesse J. Geiger joined Medpace in October 2007 as Corporate Controller, and he was appointed Chief Financial Officer in March 2011. Mr. Geiger became Chief Operating Officer, Laboratory Operations in November 2014. Mr. Geiger was appointed to the position of President on August 1, 2021. Prior to joining Medpace, Mr. Geiger worked for SENCORP from 2004 to 2007 as the Corporate Controller and Manager of Financial Planning and Analysis. Prior to SENCORP, Mr. Geiger served as the Director of Capital Markets for Cincinnati Bell from 2002 to 2004. Mr. Geiger started his career in the audit practice at Arthur Andersen LLP. Mr. Geiger has served as a director for several private companies, including as a director of LIB Therapeutics, LLC since 2015 and as a director of CinRx Pharma, LLC since 2015. Mr. Geiger received his Bachelor of Business Administration in Accounting from the University of Cincinnati and is a Certified Public Accountant.

What is Jesse J. Geiger's net worth?

The estimated net worth of Jesse J. Geiger is at least $3.16 million as of April 14th, 2021. Mr. Geiger owns 9,382 shares of Medpace stock worth more than $3,164,361 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Geiger may own. Additionally, Mr. Geiger receives a salary of $945,080.00 as CFO at Medpace. Learn More about Jesse J. Geiger's net worth.

How old is Jesse J. Geiger?

Mr. Geiger is currently 50 years old. There are 5 older executives and no younger executives at Medpace. The oldest executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who is 68 years old. Learn More on Jesse J. Geiger's age.

What is Jesse J. Geiger's salary?

As the CFO of Medpace Holdings, Inc., Mr. Geiger earns $945,080.00 per year. There are 2 executives that earn more than Mr. Geiger. The highest earning executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who commands a salary of $1,650,000.00 per year. Learn More on Jesse J. Geiger's salary.

How do I contact Jesse J. Geiger?

The corporate mailing address for Mr. Geiger and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at [email protected]. Learn More on Jesse J. Geiger's contact information.

Has Jesse J. Geiger been buying or selling shares of Medpace?

Jesse J. Geiger has not been actively trading shares of Medpace in the last ninety days. Most recently, Jesse J. Geiger sold 3,000 shares of the business's stock in a transaction on Wednesday, April 14th. The shares were sold at an average price of $180.00, for a transaction totalling $540,000.00. Following the completion of the sale, the chief financial officer now directly owns 9,382 shares of the company's stock, valued at $1,688,760. Learn More on Jesse J. Geiger's trading history.

Who are Medpace's active insiders?

Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.

Are insiders buying or selling shares of Medpace?

In the last twelve months, insiders at the sold shares 11 times. They sold a total of 218,961 shares worth more than $88,468,498.45. The most recent insider tranaction occured on May, 28th when CEO August J Troendle sold 5,695 shares worth more than $2,252,315.55. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.

Information on this page was last updated on 5/28/2024.

Jesse J. Geiger Insider Trading History at Medpace

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/14/2021Sell3,000$180.00$540,000.009,382View SEC Filing Icon  
2/10/2021Sell4,000$160.00$640,000.0010,382View SEC Filing Icon  
9/1/2020Sell3,110$130.00$404,300.0010,082View SEC Filing Icon  
12/19/2019Sell14,400$82.00$1,180,800.0016,948View SEC Filing Icon  
10/14/2019Sell7,200$78.03$561,816.0040,948View SEC Filing Icon  
4/1/2019Sell25,037$60.00$1,502,220.0025,037View SEC Filing Icon  
3/29/2019Sell12,000$58.20$698,400.0025,037View SEC Filing Icon  
8/2/2018Sell7,407$60.15$445,531.05View SEC Filing Icon  
See Full Table

Jesse J. Geiger Buying and Selling Activity at Medpace

This chart shows Jesse J Geiger's buying and selling at Medpace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medpace Company Overview

Medpace logo
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Read More

Today's Range

Now: $337.28
Low: $334.00
High: $342.50

50 Day Range

MA: $339.14
Low: $308.93
High: $363.58

2 Week Range

Now: $337.28
Low: $277.72
High: $459.77

Volume

683,001 shs

Average Volume

284,230 shs

Market Capitalization

$10.48 billion

P/E Ratio

29.53

Dividend Yield

N/A

Beta

1.37